Patents by Inventor Werner Oberegger

Werner Oberegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
    Patent number: 10668084
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: June 2, 2020
    Assignee: Acerus Biopharma Inc.
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
    Patent number: 10111888
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: October 23, 2015
    Date of Patent: October 30, 2018
    Assignee: ACERUS BIOPHARMA INC.
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
    Patent number: 9757388
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Grant
    Filed: May 14, 2012
    Date of Patent: September 12, 2017
    Assignee: Acerus Pharmaceuticals SRL
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • Modified release formulations of a bupropion salt
    Patent number: 9504640
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: September 2, 2014
    Date of Patent: November 29, 2016
    Assignee: Valeant Pharmaceuticals Luxembourg S.Á.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • INTRANASAL 0.15% AND 0.24% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160271144
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 23, 2015
    Publication date: September 22, 2016
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • INTRANASAL 0.45% AND 0.48% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160250228
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 23, 2015
    Publication date: September 1, 2016
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20160175321
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: October 20, 2015
    Publication date: June 23, 2016
    Inventors: Wayne Carper, Siobhan Fogarty, Werner Oberegger, Paul José Pierre Marie Maes
  • CONTROLLED RELEASE TOPICAL TESTOSTERONE FORMULATIONS AND METHODS
    Publication number: 20160113946
    Abstract: The present invention relates to testosterone topical formulations, especially high testosterone concentration formulations, such as between about 6% to about 15% w/w or higher, for the controlled release of testosterone into the systemic circulation of males and females for providing constant effective testosterone blood levels, without inducing undesired testosterone spike in blood levels or testosterone transference, following topical administration. The testosterone topical formulations of the present invention are safe, convenient to use, well tolerated, stable and easily and reproducibly manufactured on scale up. Moreover, because supra-normal and sub-normal testosterone blood levels are believed to be essentially kept to a minimum or avoided and the testosterone serum levels are believed to remain essentially constant during dose life, i.e.
    Type: Application
    Filed: May 15, 2015
    Publication date: April 28, 2016
    Inventors: Werner Oberegger, Paul José Pierre Marie Maes
  • CONTROLLED RELEASE TOPICAL TESTOSTERONE FORMULATIONS AND METHODS
    Publication number: 20150297733
    Abstract: The present invention relates to testosterone topical formulations, especially high testosterone concentration formulations, such as between about 6% to about 15% w/w or higher, for the controlled release of testosterone into the systemic circulation of males and females for providing constant effective testosterone blood levels, without inducing undesired testosterone spike in blood levels or testosterone transference, following topical administration.
    Type: Application
    Filed: November 14, 2013
    Publication date: October 22, 2015
    Inventors: Werner Oberegger, Paul José Pierre Marie Maes
  • Modified Release Formulations Of A Bupropion Salt
    Publication number: 20150202147
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 23, 2015
    Applicant: VALEANT INTERNATIONAL BERMUDA
    Inventors: Werner OBEREGGER, Fang ZHOU, Paul MAES, Stefano TURCHETTA, Graham JACKSON, Pietro MASSARDO, Mohammad Ashty SALEH
  • Modified release formulations of a bupropion salt
    Patent number: 8932628
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 13, 2007
    Date of Patent: January 13, 2015
    Assignee: Valeant International Bermuda
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Graham Jackson, Mohammad Ashty Saleh
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20130266650
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: January 28, 2013
    Publication date: October 10, 2013
    Inventors: Graham JACKSON, Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • INTRANASAL 0.6% AND 0.72% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130059827
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: March 7, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.15% AND 0.24% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130045958
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 21, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL 0.45% AND 0.48% TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040922
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • INTRANASAL LOWER DOSAGE STRENGTH TESTOSTERONE GEL FORMULATIONS AND USE THEREOF FOR TREATING ANORGASMIA OR HYPOACTIVE SEXUAL DESIRE DISORDER
    Publication number: 20130040923
    Abstract: The present invention relates to lower dosage strength pernasal testosterone gel formulations for intranasal administration and treatment methods for using the lower dosage strength pernasal testosterone gel formulations for treating a female subject with anorgasmia and/or hypoactive sexual desire disorder.
    Type: Application
    Filed: May 14, 2012
    Publication date: February 14, 2013
    Applicant: Trimel Pharmaceuticals Corporation
    Inventors: Wayne Kreppner, Siobhan Fogarty, Werner Oberegger, Paul Maes
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20110052684
    Abstract: The present invention relates to a pharmaceutical composition comprising a tablet core comprising a combination of actives selected from the group consisting of bupropion hydrochloride and escitalopram oxalate, bupropion hydrobromide and citalopram hydrochloride, bupropion hydrobromide and escitalopram oxalate, and bupropion hydrobromide and quetiapine fu-marate, and at least one pharmaceutically acceptable excipient, and a control-releasing coat surrounding the tablet core, wherein said composition surprisingly provides for a synchronous release of the combination of active agents in-vitro. The once-daily pharmaceutical composition surprisingly also provides for enhanced absorption of bupropion hydrobromide when administered to a subject in need of such administration.
    Type: Application
    Filed: January 28, 2009
    Publication date: March 3, 2011
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Edwin Walsh, Graham Jackson, Werner Oberegger, Xiaopin Jin
  • Modified-release formulations of a bupropion salt
    Patent number: 7884136
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Grant
    Filed: June 27, 2006
    Date of Patent: February 8, 2011
    Assignee: Biovail Laboratories International S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh
  • BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS
    Publication number: 20100255094
    Abstract: Bupropion hydrobromide formulations as well as their use for the treatment of conditions is described.
    Type: Application
    Filed: October 28, 2008
    Publication date: October 7, 2010
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL SRL
    Inventors: Graham Jackson, Werner Oberegger, Paul Maes, Mohammad Ashty Saleh
  • MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT
    Publication number: 20100222435
    Abstract: The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of bupropion hydrobromide, and the use of the bupropion salt to prepare a medicament to treat a condition.
    Type: Application
    Filed: June 27, 2006
    Publication date: September 2, 2010
    Applicant: BIOVAIL LABORATORIES INTERNATIONAL S.R.L.
    Inventors: Werner Oberegger, Fang Zhou, Paul Maes, Stefano Turchetta, Graham Jackson, Pietro Massardo, Mohammad Ashty Saleh